(BGS) B&G Foods - Ratings and Ratios
Frozen Vegetables, Canned Beans, Hot Cereals, Spices, Pickles
Dividends
| Dividend Yield | 19.87% |
| Yield on Cost 5y | 4.99% |
| Yield CAGR 5y | -20.47% |
| Payout Consistency | 94.0% |
| Payout Ratio | 140.7% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 49.8% |
| Value at Risk 5%th | 70.2% |
| Relative Tail Risk | -14.32% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.37 |
| Alpha | -34.15 |
| CAGR/Max DD | -0.28 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.449 |
| Beta | 0.206 |
| Beta Downside | 0.327 |
| Drawdowns 3y | |
|---|---|
| Max DD | 70.97% |
| Mean DD | 40.22% |
| Median DD | 42.46% |
Description: BGS B&G Foods October 26, 2025
B&G Foods Inc. (NYSE:BGS) is a diversified manufacturer and distributor of shelf-stable and frozen foods, as well as household products, operating primarily in the United States, Canada, and Puerto Rico. The company’s portfolio spans over 100 brands-including iconic names such as Green Giant, Cream of Wheat, and Ortega-and covers categories from canned vegetables and cooking oils to hot cereals, sauces, and specialty snacks. Sales are executed both directly and through a broad network of independent brokers, distributors, and retail partners ranging from supermarket chains to warehouse clubs.
Key operating metrics (FY 2023) show revenue of roughly $2.5 billion, an adjusted EBITDA margin near 9 %, and a net income of $115 million, reflecting modest profitability in a low-growth, price-sensitive segment. The packaged foods sector remains vulnerable to inflation-driven input cost volatility (e.g., commodity prices for corn and canola) and shifting consumer preferences toward private-label and healthier options, which compress margins for legacy brands. B&G’s balance sheet carries $1.2 billion of total debt, giving a leverage ratio of about 3.5× EBITDA, a level that warrants monitoring given potential interest-rate headwinds.
If you want a data-rich, forward-looking assessment of BGS-including consensus earnings forecasts, valuation multiples, and scenario-based risk analysis-consider pulling the company’s profile on ValueRay for a deeper dive.
Piotroski VR‑10 (Strict, 0-10) 1.0
| Net Income (-250.5m TTM) > 0 and > 6% of Revenue (6% = 110.4m TTM) |
| FCFTA 0.02 (>2.0%) and ΔFCFTA -1.50pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 30.53% (prev 17.60%; Δ 12.93pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.03 (>3.0%) and CFO 86.3m > Net Income -250.5m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 3.20 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (80.0m) change vs 12m ago 0.74% (target <= -2.0% for YES) |
| Gross Margin 21.44% (prev 21.87%; Δ -0.43pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 57.87% (prev 57.31%; Δ 0.57pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -1.21 (EBITDA TTM -100.6m / Interest Expense TTM 151.2m) >= 6 (WARN >= 3) |
Altman Z'' 1.58
| (A) 0.19 = (Total Current Assets 816.9m - Total Current Liabilities 254.9m) / Total Assets 2.94b |
| (B) 0.16 = Retained Earnings (Balance) 465.0m / Total Assets 2.94b |
| (C) -0.06 = EBIT TTM -182.6m / Avg Total Assets 3.18b |
| (D) 0.19 = Book Value of Equity 470.7m / Total Liabilities 2.47b |
| Total Rating: 1.58 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 23.36
| 1. Piotroski 1.0pt |
| 2. FCF Yield 2.30% |
| 3. FCF Margin 2.97% |
| 4. Debt/Equity 4.40 |
| 5. Debt/Ebitda -19.99 |
| 6. ROIC - WACC (= -7.75)% |
| 7. RoE -49.85% |
| 8. Rev. Trend -63.25% |
| 9. EPS Trend -55.61% |
What is the price of BGS shares?
Over the past week, the price has changed by +5.75%, over one month by +2.36%, over three months by +10.88% and over the past year by -28.77%.
Is BGS a buy, sell or hold?
- Strong Buy: 0
- Buy: 0
- Hold: 5
- Sell: 0
- Strong Sell: 2
What are the forecasts/targets for the BGS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 4.1 | -14.2% |
| Analysts Target Price | 4.1 | -14.2% |
| ValueRay Target Price | 5 | 4.6% |
BGS Fundamental Data Overview December 10, 2025
P/E Forward = 8.6207
P/S = 0.1986
P/B = 0.7764
P/EG = 7.93
Beta = 0.428
Revenue TTM = 1.84b USD
EBIT TTM = -182.6m USD
EBITDA TTM = -100.6m USD
Long Term Debt = 2.02b USD (from longTermDebt, last quarter)
Short Term Debt = 19.6m USD (from shortTermDebt, last quarter)
Debt = 2.07b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.01b USD (from netDebt column, last quarter)
Enterprise Value = 2.38b USD (365.6m + Debt 2.07b - CCE 60.9m)
Interest Coverage Ratio = -1.21 (Ebit TTM -182.6m / Interest Expense TTM 151.2m)
FCF Yield = 2.30% (FCF TTM 54.8m / Enterprise Value 2.38b)
FCF Margin = 2.97% (FCF TTM 54.8m / Revenue TTM 1.84b)
Net Margin = -13.61% (Net Income TTM -250.5m / Revenue TTM 1.84b)
Gross Margin = 21.44% ((Revenue TTM 1.84b - Cost of Revenue TTM 1.45b) / Revenue TTM)
Gross Margin QoQ = 22.50% (prev 20.49%)
Tobins Q-Ratio = 0.81 (Enterprise Value 2.38b / Total Assets 2.94b)
Interest Expense / Debt = 1.83% (Interest Expense 38.0m / Debt 2.07b)
Taxrate = 23.64% (-5.93m / -25.1m)
NOPAT = -139.4m (EBIT -182.6m * (1 - 23.64%)) [loss with tax shield]
Current Ratio = 3.20 (Total Current Assets 816.9m / Total Current Liabilities 254.9m)
Debt / Equity = 4.40 (Debt 2.07b / totalStockholderEquity, last quarter 470.7m)
Debt / EBITDA = -19.99 (negative EBITDA) (Net Debt 2.01b / EBITDA -100.6m)
Debt / FCF = 36.73 (Net Debt 2.01b / FCF TTM 54.8m)
Total Stockholder Equity = 502.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -8.51% (Net Income -250.5m / Total Assets 2.94b)
RoE = -49.85% (Net Income TTM -250.5m / Total Stockholder Equity 502.5m)
RoCE = -7.24% (EBIT -182.6m / Capital Employed (Equity 502.5m + L.T.Debt 2.02b))
RoIC = -5.55% (negative operating profit) (NOPAT -139.4m / Invested Capital 2.51b)
WACC = 2.20% (E(365.6m)/V(2.44b) * Re(6.77%) + D(2.07b)/V(2.44b) * Rd(1.83%) * (1-Tc(0.24)))
Discount Rate = 6.77% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 0.87%
[DCF Debug] Terminal Value 71.32% ; FCFE base≈78.8m ; Y1≈53.8m ; Y5≈26.5m
Fair Price DCF = 6.44 (DCF Value 515.2m / Shares Outstanding 80.0m; 5y FCF grow -37.19% → 3.0% )
EPS Correlation: -55.61 | EPS CAGR: -22.49% | SUE: 0.26 | # QB: 0
Revenue Correlation: -63.25 | Revenue CAGR: -6.79% | SUE: 0.29 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.04 | Chg30d=-0.022 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=0.50 | Chg30d=-0.005 | Revisions Net=+0 | Growth EPS=-4.5% | Growth Revenue=-1.8%
Additional Sources for BGS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle